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Abstract: Prior research had been carried out to identify a large number of glycaemic variables in sparse, 
noisy data from a virtual diabetic patient. This paper investigates the precision of variables as an 
identification scheme introduces progressively more parameters into the variable set and as the quantity of 
data increases. Virtual data was simulated with a diabetic glycaemic meal model that contained six variable 
parameters. Data was sampled 6 times daily with noise. Increasing variable sets were identified for data 
subsets of increasing size. Norm-error of equivalent variable groups was compared before and after new 
parameter introductions. A Monte Carlo analysis was carried out to evaluate a population of results. 
Identifying new variables improved parameter estimates in all equivalent variable groups by 34 days in the 
mean population case. However, variability from data noise resulted in some cases never yielding six-
parameter identification that improved upon results that relied on a-priori information. When parameters 
were introduced as variables too soon for the given data quality/quantity, reduced practical identifiability 
caused interference between these and other variables, diminishing their precision. However, when 
introduced too late the precision in the variable set was hindered by effects not fully described by the a-
priori guesses. Introducing the 3rd and 4th variables early in the data produced significant benefit in most 
cases. In contrast, the 5th and 6th parameters could not be introduced as early, improved precision by a lesser 
degree on average and in many cases never improved precision. The influence of noise on practical 
identifiability highlighted the need for similar analyses in-vivo so as to strategise parameter identification 
to gain the most information at the highest precision. 
Keywords: parameter identification, identifiability, physiological models, Monte Carlo simulation, type 1 
diabetes, stress hyperglycaemia, exercise 
 
1. INTRODUCTION 
Individuals with type 1 diabetes mellitus take regular doses of 
insulin to overcome an almost complete lack of pancreatic 
insulin production. The goal of insulin therapy is to minimise 
postprandial hyperglycaemia, while maintaining low risk of 
hypoglycaemia (Rubin and Peyrot, 2001). Both states are 
associated with reduced quality of life and a number of serious 
health complications (Rubin and Peyrot, 1999, De Boer et al., 
2008, Retnakaran and Zinman, 2008, Shankar et al., 2007). 
The optimal insulin dose for a given meal depends largely on 
the carbohydrate content and the insulin sensitivity (SI) of the 
patient, but many smaller and unquantified influences are also 
in effect, which can add significant complication to self-
managed blood glucose (BG) control of the most diligent 
individuals. Stress, fatigue, and circadian metabolic rhythms 
are factors that modify the effective SI (Surwit et al., 1992, 
Räikkönen et al., 1996, Lloyd et al., 1999). Furthermore, 
exercise has a significant effect on the rate of glucose 
disappearance (Sonnenberg et al., 1990, Roy and Parker, 2007, 
Yardley et al., 2013). The ability to quantify these unmeasured 
‘secondary effects’ for specific individuals has the potential to 
improve self-regulated normo-glycaemia. 
In prior research we identified seven glycaemic parameters in 
sparse BG data from a virtual patient (Mansell, et al., 
unpublished). The results of the Monte Carlo analyses proved 
the parameters were all observable, and that measurement 
noise and un-modelled effects could be overcome as data size 
increased, with coefficient of variation  (CV) across the 
population reducing in proportion to 1/√𝑛 and only small 
(<1%) biases resulting after one year (Mansell et al., 
unpublished). To observe long-term drift in SI, a 90 day data 
window was progressed along a 2 year period to identify 
parameters in a moving average. Information for stress, fatigue 
and exercise parameters were still able to be captured with 
biases remaining less than 1% and CV being approximately 
equivalent to drift-free outcomes.  
Practical non-identifiability occurs when experimental data is 
of insufficient quality or quantity compared to the size of a 
model (Raue et al., 2009, Docherty et al., 2011). This paper 
investigates identifiability in the six most variable parameters 
  
 
     
from the original seven-parameter cohort. Specifically, we aim 
to determine the data quantity required to support all six 
parameters without encountering such parameter interference. 
2. METHODS  
All analysis used MATLAB R2014a.  
2.1 Simulating virtual patient model 
Glycaemic dynamics for the virtual patient were modelled 
using a variation of DISST (Lotz et al., 2010) and nutrition 
models (Wong et al., 2008a, Wong et al., 2008b). These were 
further modified to include secondary effect parameters for 
stress, fatigue, exercise and circadian rhythms of SI. The first 
order, multi-compartmental model consisted of many constant 
parameters (definitions in Table 1) and time-dependent inputs 
(Table 2), some of which were randomised in occurrence 
and/or magnitude for each repetition of the patient for the 
Monte Carlo analysis. 
Subcutaneous insulin (US) absorbed from regular insulin 
boluses (UX) was modelled with the analytical solution to: 
Interstitial insulin concentration (Q), dependant on US and 
plasma insulin (I), was simulated with a true analytical 
solution to Equations 2 and 3 found with MATLAB’s 
symbolic differential equation solver (dsolve) assuming the 
initial state is at equilibrium: 
?̇?(𝑡) =  −(𝑛𝐼 + 𝑛𝐶)𝑄(𝑡) + 𝑛𝐼𝐼(𝑡) (2) 
𝐼(̇𝑡) = −(𝑛𝑇 + 𝑛𝐼)𝐼(𝑡) + 𝑛𝐼𝑄(𝑡) + 𝑘𝑋𝑈𝑆(𝑡) 𝑉𝑃⁄  (3) 
Glucose absorbed into the gut (PS) was calculated from regular 
ingested meals of varying glucose content (PX) and randomly 
timed snacks (PC): 
𝑃?̇?(𝑡) = (𝑃𝑋(𝑡) + 𝑃𝐶(𝑡)) 𝑉𝐺⁄ − 𝑘1𝑃𝑆(𝑡) (4) 
Insulin sensitivity (SI) was modelled as a the sum of 
overlapping triangular basis functions (g1-3) multiplied by their 
corresponding morning, midday and afternoon peak insulin 
sensitivities (SI1-3), along with stress (𝜎) and fatigue (𝜑) 
modifiers: 
𝑆𝐼(𝑡) = (𝑆𝐼1𝑔1(𝑡) + 𝑆𝐼2𝑔2(𝑡) + 𝑆𝐼3𝑔3(𝑡))
× (1 − 𝜎(𝑡) − 𝜑(𝑡)) 
(5) 
The basis functions and SI profile are pictured in Figure A1, 
Appendix A, for clarification. 
BG (G) was modelled using Q, PS and SI, along with an effect 
from exercise (𝜀): 
?̇?(𝑡) = 𝑘2𝑃𝑠(𝑡) − 𝑆𝐼(𝑡)(𝐺(𝑡) ∙ 𝑄(𝑡) − 𝐺0𝑄0)
− 𝑝𝐺(𝐺(𝑡) − 𝐺0 + 𝜀(𝑡)) 
(6) 
Each of the stress, fatigue, and exercise functions was 
calculated as the product of a maximum value and a time-
dependent function with effect intensity ranging from 50-
100% for each appearance of the effect and 0% otherwise. 
𝜀(𝑡) = 𝜀𝑚𝑎𝑥  ∙ 𝑓𝜀(𝑡), 𝜎(𝑡) = 𝜎𝑚𝑎𝑥 ∙ 𝑓𝜎(𝑡),
𝜑(𝑡) = 𝜑𝑚𝑎𝑥 ∙ 𝑓𝜑(𝑡) 
(7.a-c) 
All time-dependent variables were simulated to one minute 
resolution. Definite integrals were calculated with trapezoidal 
numerical integration. 
2.2 Simulation and data sampling 
Diary-like data was created for the virtual patient where daily 
finger-prick measurements were documented and the 
carbohydrate content of meals estimated, neglecting 
‘unrecorded’ snacks. Insulin doses were recorded, as well as 
instances and intensity of exercises, stress and fatigue. 
 
Table 1. Parameter constants used to simulate the virtual patient glycaemic profiles in Equations 1-6 
Parameter Description Value Unit 
nI Plasma to interstitium transport rate 0.02 min-1 
nT Plasma insulin clearance rate 0.1 min-1 
nC Cell metabolism of insulin 0.02 min-1 
vP Volume of distribution of plasma insulin 4.3 L 
pG Glucose dependant balance 0.004 min-1 
VG Glucose distribution volume 12.4 L 
k1 Rate of glucose transfer from stomach to gut 0.05 min-1 
k2 Rate of glucose absorption from gut 0.008 min-1 
kX Rate of insulin dispersed from injection site 0.01 min-1 
G0 Basal glucose level 4.5 mmol.L-1 
Q0 Basal interstitial insulin level 4.23 mU.L-1 
𝜀𝑚𝑎𝑥  Exercise coefficient 6.5 mmol.L
-1 
𝜎𝑚𝑎𝑥   Stress coefficient 0.3  
𝜑𝑚𝑎𝑥   Fatigue coefficient 0.1  
SI1 Morning (8.30am) peak 0.8x10-3 L.mU-1.min-1. 
SI2 Midday (12pm) peak 1.0x10-3 L.mU-1.min-1. 
SI3 Afternoon (3.30pm) peak 0.6x10-3 L.mU-1.min-1. 
?̇?𝑆(𝑡) = 𝑘𝑋(𝑈𝑋(𝑡) − 𝑈𝑆(𝑡))  (1) 
  
 
     
Table 2. Time-dependent vector inputs used in patient simulation with one minute resolution 
Input Description Value Unit 
PX meals [400,500] at 0800, 1200 and 1900 hrs daily, 0 otherwise mmol 
PC snacks 160 at 52 random t per year, 0 otherwise mmol 
UX insulin doses 1000 with meals, 4 otherwise mU.min-1 
𝑓𝜀 exercise intensity ∈[0.5, 0.6, …, 1.0] at 0830 to 1030 hrs, 3 days/week, 0 otherwise  
𝑓𝜎 stress intensity ∈[0.5, 0.6, …, 1.0] 3 days per 4 weeks, 0 otherwise  
𝑓𝜑 fatigue intensity ∈[0.5, 0.6, …, 1.0] 5 days per 4 weeks, 0 otherwise  
g1 morning SI basis triangular function from 0 at 1530 hrs to 1 at 0830 to 0 at 1200 hrs  
g2 midday SI basis triangular function from 0 at 0830 hrs to 1 at 1200 to 0 at 1530 hrs  
g3 afternoon SI basis triangular function from 0 at 1200 hrs to 1 at 1530 to 0 at 0830 hrs  
In practice, to simulate the data required for parameter 
identification, 6 randomly-timed samples were taken from G(t) 
between 6am and 12 midnight daily with 10% normally 
distributed multiplicative white noise. A different PS(t) was 
calculated neglecting PC and with 10% uniformly distributed 
noise applied to PX. All remaining parameters not included in 
any identification set were treated as in Tables 1-2. 
2.3 Parameter identification 
The Gauss-Newton (GN) method of gradient descent was used 
to identify the least squares solution of variable set x by 
minimising the residual error between the sampled and 
forward-simulated BG over several iterations: 
where GS denotes the sampled data and Gi(tS,xi) denotes the 
modelled glucose concentration at the sample times (tS) and 
the present iteration (i) using the current variable set. S denotes 
the samples 1…n, where n is the number of samples.  
Parameters of interest were subsets of those in the set: 
where between 2 and all 6 of these parameters were identified 
as variables when required. Variables were initially set to 
relevant subsets of 𝐱0 = [10
−3, 10−3, 10−3, 1, 0.1, 0.1]T and 
GN iterations were continued until the tolerance criteria 
||(𝐱𝑖−1 − 𝐱𝑖 )/𝐱0||2 < 10
−4  yielded approximately 4 
significant figures of convergence precision on parameter 
estimates. 
2.4  Structural identifiability and stability checks 
When instances of exercise, stress or fatigue were not present 
in an identified period of time, 𝜀𝑚𝑎𝑥, 𝜎𝑚𝑎𝑥  and 𝜑𝑚𝑎𝑥  were set 
to zero and excluded from identification. When both stress and 
fatigue effects occurred concurrently yielding a structurally 
non-identifiable system, both parameters were excluded, as 
their effects can only be quantified when there are 
distinguishable instances (Docherty et al., 2011, Bellu et al., 
2007). 
For occasional instances in small sets of data where noise and 
un-modelled effects rendered GN identification unstable 
(when singular matrix occurred or 𝑖 > 30), latter variables 
were removed from the process every 20 iterations until 
successful identification occurred. 
2.5 Error analysis 
Proof of concept analysis was carried out as follows: 
1. 40 days of data was simulated 
2. This data was broken into subsets of 0-1,0-2,…,0-40 
days 
3. SI1-2 were identified for all data sets while other 
variables were set as ‘a-priori’ parameters using 
incorrect values: SI3 = 0.4x10-3, εmax = σmax = φmax = 0 
4. SI3 was introduced to the variable set and 
identification was again carried out over all data sets 
5. Error in SI1 and SI2 was compared for the 2-variable 
and 3-variable cases. Norm-error was calculated as 
𝑒 = ‖
𝐱−𝐱𝑡𝑟𝑢𝑒
𝐱𝑡𝑟𝑢𝑒
‖
2
where xtrue is the original model input 
6. Beneficial data size at which to introduce SI3 was 
defined as when norm-error of SI1-2 was less for the 
3-variable case than 2-variable case 
2.6 Monte Carlo analysis 
Population-wide analysis employed the following process: 
1. 89 days of data was simulated for 1000 patients 
2. These data sets were broken into subsets from zero to 
[2, 3, 5, 8, 13, 21, 34, 55, 89] days 
3. SI1-2 were identified for all data subsets for all repeats 
4. SI3, εmax, σmax, and φmax were all added to the variable 
set one at a time, with new identification occurring at 
each addition 
5. Norm-error was calculated for variable subsets x1-2 
for all results, x1-3 when 3 or more variables were 
identified, and so on up to norm-error of x1-5 for 5 and 
6 variable cases 
6. Days when an increase in the number of variables 
yielded improved precision in each previous variable 
subset were located for the population mean 
7. For the 89 day subset only, mean reduction in norm-
error for equivalent variable subsets was calculated 
for each variable introduction, defined as 1 −
?̅?𝑛𝑒𝑤/?̅?𝑜𝑙𝑑.  The fraction of non-improved cases was 
also calculated 
𝛙𝑖 = 𝐆𝑖(𝑡𝑆, 𝐱𝑖)−𝐆𝐒 (7) 
𝐱 =  [𝑆𝐼1, 𝑆𝐼2, 𝑆𝐼3, 𝜀𝑚𝑎𝑥 , 𝜎𝑚𝑎𝑥 , 𝜑𝑚𝑎𝑥]
T (8) 
  
 
     
3. RESULTS 
Figure 1 shows the SI parameter estimates when the 
identification set is 2 variables vs 3 variables. Note that the 3-
variable set yielded larger error in SI2 for days 1-10 compared 
to the 2-variable set. However, after approximately 23 days, 
the combined norm-error for SI1-2 is reduced with the 
introduction of SI3 into the variable set, Figure 2. For the MC 
population mean, the point at which a 3-variable set favoured 
the precision of SI1-2 was at four days, Figure 3. Further 
introduction of εmax, σmax, and φmax variables reduced SI1-2 
norm-error at three, nine and 34 days, Figure 4 
 
Figure 1. Identification for a data set with 2 variables plus one 
a-priori parameter (a) and all 3 as variables (b). Note: the 
legend is located at the top of the figure. 
 
Figure 2. Norm-error of SI1-2 for 2 and 3 variable identification 
sets. Prior to 23 days the least error is achieved by treating SI3 
as a-priori, afterward it is better identified as a variable. 
Figure 3. Norm-error of SI1-2 as 2 and 3 variables are identified 
over a population, reduction in error for 3 variables at 4 days. 
Figure 4. Norm error of SI1-2 as 2-6 variables are identified 
over a population. Reduced error for variable introductions 3-
6 occurs at 4, 3, 9 and 34 days. 
Further consideration was taken into to the norm-error of 
variable sets greater than just SI1-2.  
Table 1 shows that for the population mean, crossover days for 
beneficially introducing certain parameters into the variable 
set were comparable across all norm-error sets (e.g. εmax 
improves norm-error of both SI1-2 and SI1-3 after 3 days). 
Additionally, the crossover days generally increased for 
subsequent variable additions (e.g. the 5th parameter, σmax, can 
be introduced as a variable on average 3 days after the 4th 
parameter, εmax). 
Table 2 gives statistics for the degree of norm-error 
improvement after 89 days for each increase in variable 
number. Identifying SI3 reduced norm-error in SI1-2 by 29% on 
average, only failing to improve the error in 1% of cases. 
Introducing the exercise parameter, εmax, produced greater 
mean error reductions (28 and 41% for SI1-2 and SI1-3), but also 
had a greater no-benefit rate of 6-18%. Introducing stress, σmax, 
and fatigue, φmax, as variables had less benefit in error 
reduction, especially for φmax, where mean reductions ranged 
from an increase in error of 6% to a reduction of 6% and no-
benefit rates were 28-40%. 
Table 1. Mean day for an introduced parameter to improve 
precision in other variable sets. 
parameter 
introduced 
variable subset evaluated 
x1-2 x1-3 x1-4 x1-5 average 
x3 = SI3 4    4 
x4 = εmax 3 3   3 
x5 = σmax 9 5 5  6 
x6 = φmax 34 27 27 26 29 
  
 
     
Table 2. Population variability statistics for 89 days of data 
with mean reduction in norm-error for parameter sets as 
subsequent parameters were introduced and the no-benefit 
rate where precision was not improved.  
parameter 
introduced 
statistic 
variable subset evaluated 
x1-2 x1-3 x1-4 x1-5 
x3 = SI3 
reduction  29%    
no-benefit 1.3%    
x4 = εmax 
reduction 28% 41%   
no-benefit 18% 6.2%   
x5 = σmax 
reduction 9.0% 23% 16%  
no-benefit 20% 8.6% 16%  
x6 = φmax 
reduction -6.2% 6.2% 3.7% 2.6% 
no-benefit 40% 28% 34% 36% 
4. DISCUSSION 
Introducing a new parameter into the identified set of variables 
can reduce the error of the original variables due to the ability 
of the introduced parameter to assume a value that has less 
associated error than an a-priori guess. A comparison of 
Figure 1a and 1b shows that by the end of 40 days, the error in 
SI1-3 was less when SI3 was identified as a variable, rather than 
taken as an incorrect a-priori parameter. However, too little 
data results negates this beneficial effect. Figure 1b shows that 
identifying SI3 introduced large error in SI2 for small n. This 
outcome demonstrates that, at first, the data was not sufficient 
to support all the variables with any degree of accuracy, and 
reduced practical identifiability resulted in variable 
interference (Raue et al., 2009, Docherty et al., 2011).  
SI1-3 are equivalent parameters that peak at different times of 
the day. Hence the times at which data points were taken 
would influence accuracy in SI1-3 estimates. For example, if 
data points have largely been sampled in the morning, then the 
effect of the afternoon SI is not easily distinguishable, and the 
resulting error may propagate particularly strongly into the 
midday SI, as was the likely case in Figure 1b. As more data 
accumulated, with more random additions inevitably 
occurring in the afternoon, the afternoon SI began to achieve 
accuracy and all variables were benefited. This illustrates the 
concept of practical identifiability well. 
While mean population results appear to indicate cleanly when 
parameters should be introduced as variables (Figure 4), the 
trends fail to capture variability effects and thus represent an 
ideal case rather than average. In particular the mean averages 
out error, the y-dimension property in Figure 4, but not the 
crossover day when the variable set can be increased, the x-
dimension property. In fact, for individual sets of data there 
were frequently multiple crossovers points or none at all in the 
first 89 days. This reality cannot be captured by the mean, thus 
the statistical data of Table 2 was calculated.  
Based on results for variability effects, SI3 appears beneficial 
to introduce by day 89 since it reduced norm-error of SI1-2 in 
99% of cases. Since the appearance of SI3 was daily, its 
accuracy weighed heavily on the outcomes of other variables. 
Comparatively, stress occurred much less frequently and had 
lower gains for greater risk (no-benefit rate 9-20%). Exercise, 
εmax, also appears beneficial to introduce with large benefits 
(28-41%) though a moderate no-benefit rate (6-18%). Since 
the model includes frequent exercise at the same time of day, 
not identifying εmax is likely to skew at least one SI peak value, 
thus the risk could be deemed acceptable compared to the 
benefits. Like stress, fatigue was relatively infrequent. Thus, 
many more days of data were required to achieve accuracy and 
minimise interference with other variables. This can be seen in 
the higher no-benefit rates (28-40%) and lower gains (-6% to 
6% error reduction). Perhaps both σmax and φmax should not be 
identified due to their tendency for error propagation. 
Of course, while introducing some parameters is likely to 
increase error in other parameters, this detriment must be 
weighed against the benefit identifying the new parameter 
itself. A small error increase could be an acceptable price for 
the advantageous information. However, a best case for all 
parameters could be achieved by identifying a base parameter 
set of regular and highly identifiable parameters, then fixing 
some or all of these parameters while performing a second 
identification round to ascertain the less frequent parameters. 
An in-silico analysis was the best platform for investigating 
the research presented in this paper since true parameters 
values are non-existent in real data. Therapeutic glycaemic 
modelling can be difficult in practice because of the presence 
of noise, un-modelled effects and sometimes practical non-
identifiability. We have shown that much of these effects can 
be accounted for in a stable manner through the timely addition 
of new parameters into the identified set of variables. It 
remains unknown how real data would respond to equivalent 
parameter introductions. However, the concepts explored act 
as a starting point to developing and testing the efficacy of 
other analysis methods independent of error and perhaps 
instead evaluating properties such as variability. 
There are many factors that can affect the glycaemic dynamics 
of people with diabetes to some tangible degree, not limited to 
those modelled in this report. The ability to identify a large 
number of such parameters in one set of data would be 
valuable. However, if certain parameters are introduced too 
soon in the accumulation of data, they can seriously reduce the 
precision of the other parameter estimates. If introduced too 
late, then un-modelled behaviour, or ‘grey’ noise, is the 
limiting factor on the precision of identified variables. Hence 
the importance of this type of identifiability analysis. 
5.  CONCLUSIONS 
Identification of increasing numbers of parameters generally 
improves error in the parameter group by capturing otherwise 
un-modelled effects. However insufficient data can reduce 
practical identifiability, increasing parameter interference and 
error. The point at which data does become sufficient was 
diagnosed through analysis of error in equivalent variable sets 
before and after parameter introduction. 
Specific to this model and analysis, the two parameters SI3 and 
εmax appear reasonably beneficial to introduce after 89 days, 
while σmax and φmax may be better excluded until the other 
parameters can be well established and fixed. 
  
 
     
Error-based analysis was ideal for exploring the effect of 
practical identifiability on the model, but will ultimately be 
ineffective for in vivo data, requiring improved methods. 
Identifying large numbers of parameters with known 
confidence would be useful in diabetes. Greater knowledge of 
secondary glycaemic factors, could achieve improved 
glycaemic control with greater lifestyle flexibility. 
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Appendix A. VISUAL CLARIFICATION OF INSULIN 
SENSITIVITY PROFILE 
 
Figure A1. The triangular basis functions g1-3 (a) used to 
achieve the SI profile (b) with Equation 6. 
